Cardura XL

See also: Generic Cardura

Cardura XL is a brand name of doxazosin, approved by the FDA in the following formulation(s):

CARDURA XL (doxazosin mesylate - tablet, extended release; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: February 22, 2005
  
  Strength(s): EQ 4MG BASE, EQ 8MG BASE ^[RLD]

Has a generic version of Cardura XL been approved?

No. There is currently no therapeutically equivalent version of Cardura XL available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cardura XL. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Cardura XL.

See also...

• Cardura XL Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Cardura XL Consumer Information (Cerner Multum)
• Cardura XL Advanced Consumer Information (Micromedex)
• Doxazosin Consumer Information (Drugs.com)
• Doxazosin Consumer Information (Wolters Kluwer)
• Doxazosin Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Doxazosin Consumer Information (Cerner Multum)
• Doxazosin Advanced Consumer Information (Micromedex)
• Doxazosin Mesylate AHFS DI Monographs (ASHP)